Clinical Trial Update: Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of CAR T-cell therapy for acute myeloid leukemia and multiple myeloma has terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma

Snippet

Sponsor: AGC Biologics S.p.A. | Conditions: Acute Myeloid Leukemia, Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-01-19